David M. Stout is on the board of Jabil, Inc. and BlueWillow Biologics, Inc.

He previously occupied the position of President at US Pharmaceuticals, Inc., Chairman at Vaxxilon AG, President at Schering-Plough Corp., President for Schering Laboratories Advertising, Inc., Principal at Warner-Lambert Co., President-Pharmaceuticals Division at GlaxoSmithKline LLC and Senior VP, Director-US Sales & Marketing at Smithkline Beecham Plc.

He received an undergraduate degree from McDaniel College.